Using HIV resistance tests in clinical practice.

Research output: Contribution to journalReview article

Standard

Using HIV resistance tests in clinical practice. / Taylor, Stephen; Jayasuriya, A; Smit, E.

In: Journal of Antimicrobial Chemotherapy, Vol. 64, No. 2, 01.08.2009, p. 218-22.

Research output: Contribution to journalReview article

Harvard

APA

Vancouver

Author

Taylor, Stephen ; Jayasuriya, A ; Smit, E. / Using HIV resistance tests in clinical practice. In: Journal of Antimicrobial Chemotherapy. 2009 ; Vol. 64, No. 2. pp. 218-22.

Bibtex

@article{2a1ef32ba3754404bf5792f5a3e111ea,
title = "Using HIV resistance tests in clinical practice.",
abstract = "Genotypic resistance testing is now a standard of care in HIV management. Although there are clear, published guidelines to recommend the appropriate use of these tests, clinicians and scientists still struggle to determine the optimal use of resistance tests given the finite budgets and time constraints under which they work. In this article we discuss some 'real-life' clinical situations and aim to provide a useful insight into when and where genotypic resistance testing can be optimally applied in the management of HIV-positive adults.",
author = "Stephen Taylor and A Jayasuriya and E Smit",
year = "2009",
month = aug,
day = "1",
doi = "10.1093/jac/dkp205",
language = "English",
volume = "64",
pages = "218--22",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Using HIV resistance tests in clinical practice.

AU - Taylor, Stephen

AU - Jayasuriya, A

AU - Smit, E

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Genotypic resistance testing is now a standard of care in HIV management. Although there are clear, published guidelines to recommend the appropriate use of these tests, clinicians and scientists still struggle to determine the optimal use of resistance tests given the finite budgets and time constraints under which they work. In this article we discuss some 'real-life' clinical situations and aim to provide a useful insight into when and where genotypic resistance testing can be optimally applied in the management of HIV-positive adults.

AB - Genotypic resistance testing is now a standard of care in HIV management. Although there are clear, published guidelines to recommend the appropriate use of these tests, clinicians and scientists still struggle to determine the optimal use of resistance tests given the finite budgets and time constraints under which they work. In this article we discuss some 'real-life' clinical situations and aim to provide a useful insight into when and where genotypic resistance testing can be optimally applied in the management of HIV-positive adults.

U2 - 10.1093/jac/dkp205

DO - 10.1093/jac/dkp205

M3 - Review article

C2 - 19535382

VL - 64

SP - 218

EP - 222

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 2

ER -